Josh Raskin

“I guess just first on the numbers, the guidance for 1Q, the revenues indicate a slight decline on a year-over-year basis, whereas, you know, full year 2026, revenue is expected to be up slightly.”

“Can you speak to tech investments, including AI, and maybe advancements that you're making on your model for physicians? I'm interested in any new capabilities that you've implemented, maybe efficiencies you're seeing on both the administrative side and the revenue cycle side.”

“And, Salm, appreciate what you just said. I sort of looked at it. Margins are up 680 basis points since 2019, and the hospital segment's up 660 basis points, so it's not really mixed.”

“I'll apologize for redundancy and where I think I'm going. But, you know, as you mentioned, the individual margins that are slightly negative in 2026. So going back to the investor day from June, is there anything you've seen that changes your view of the ultimate margin profile of this now larger book of business?”

“Sort of a two-parter on the Medicaid side. Is there a large variance that remains across your states with regard to Medicaid margins? And are you at the point in any state where you're contemplating a potential exit?”